They found that a low plasma baseline concentration of both VEGF-A and ANGPT-2 predicted prolonged survival in HCC patients, whereas elevated plasma baseline concentration of ANGPT-2 was correlated with more aggressive tumors [104]. This evidence concerns the gene VEGFA and hepatocellular carcinoma.